Global FKM and FFKM Market Growth 2025-2031

According to this study, the global CXO Services market size will reach US$ 161583 million by 2031.

CXO Services refer to a broad category of outsourced services provided to pharmaceutical, biotechnology, and life sciences companies to support the development, manufacturing, and commercialization of drugs and therapeutics. The term "CXO" collectively represents contract-based services, in this report, CXO include CRO and CDMO.

United States market for CXO Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for CXO Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for CXO Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key CXO Services players cover Lonza, Catalent, Samsung Biologics, FUJIFILM Diosynth Biotechnologies, Boehringer Ingelheim, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “CXO Services Industry Forecast” looks at past sales and reviews total world CXO Services sales in 2024, providing a comprehensive analysis by region and market sector of projected CXO Services sales for 2025 through 2031. With CXO Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CXO Services industry.

This Insight Report provides a comprehensive analysis of the global CXO Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on CXO Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global CXO Services market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CXO Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CXO Services.

This report presents a comprehensive overview, market shares, and growth opportunities of CXO Services market by product type, application, key players and key regions and countries.

Segmentation by Type:
CRO
CDMO

Segmentation by Application:
Pharmaceutical Companies
Medical Device Companies
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Lonza
Catalent
Samsung Biologics
FUJIFILM Diosynth Biotechnologies
Boehringer Ingelheim
Wuxi AppTec
Charles River
Labcorp
Eurofins Scientific
PPD, Inc.
ICON Plc.
Pharmaron
Recipharm
Thermo Fisher Scientific
AGC Biologics
Rentschler Biopharma
KBI Biopharma
Siegfried
Aenova Group
GenScript
ProBioGen
Northway Biotech
3P Biopharmaceuticals
Inotiv
ChemPartner
JOINN Lab
EVOTEC
Medicilon
Crown Bioscience
Champion Oncology
IQVIA
Parexel
Syneos Health
PRA Health Sciences
Medpace Holdings
Tigermed
Boji Medical Technology

Please note: The report will take approximately 2 business days to prepare and deliver. Show more